Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

‘Zombie’ gene may protect elephants from cancer
Elephants possess an anti-cancer gene that can return from the dead.
Gene returns to life and kills cells with damaged DNA

A ‘zombie’ gene inherent in elephants may help to protect them against cancer, according to new research.

Humans and animals have one copy of the master suppressor gene, p53. The gene allows the body to recognise un-repaired DNA damage, a precursor of cancer, and causes those damaged cells to die.

But researchers at the Universities of Chicago and Utah recently found that elephants have 20 copies of p53. This makes their cells far more sensitive to damaged DNA and therefore quicker to die.

Now, new research reported in the journal Cell Reports details the second element of this process: an anti-cancer gene that can return from the dead.

“Genes duplicate all the time,” said Vincent Lynch, assistant professor of human genetics at the University of Chicago and the study’s senior author. “Sometimes they make mistakes, producing non-functional versions known as pseudogenes. We often refer to these dismissively as dead genes.”

While studying p53 in elephants, Lynch and his team discovered a former pseudogene - leukaemia inhibitory factor 6 (LIF6) - that had, by some means, evolved a new on-switch.

LIF6, which had returned from the dead, had become a valuable working gene. When activated by p53, its function is to respond to damaged DNA by killing the cell.

The LIF6 gene makes a protein that goes to the mitochondria, the cell’s main energy source. That protein pokes holes in the mitochondria, causing the cell to die.

“Hence, zombie,” said Lynch. “This dead gene came back to life. When it gets turned on by damaged DNA, it kills that cell, quickly. This is beneficial because it acts in response to genetic mistakes, errors made when the DNA is being repaired. Getting rid of that cell can prevent subsequent cancer.”

The researchers note that exactly how LIF6 triggers apoptosis remains unclear and will be the focus of future studies.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.